Arkolith/Insider Trading/CYTK/Form 4

Lee Sung

EVP, Chief Financial OfficerCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Jun 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
15
8 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)23K$48.51$1.1M87K
Jun 24, 2026Option exercise(M)9K$44.36$413K96K
Jun 24, 2026Option exercise(M)3K$44.36$125K99K
Jun 24, 2026Option exercise(M)1K$48.51$54K100K
Jun 24, 2026Option exercise(M)188$44.36$8K100K
Jun 24, 2026Option exercise(M)822$44.36$36K101K
Jun 24, 2026Option exercise(M)1K$48.51$54K102K
Jun 24, 2026Sell(S)39K$82.30$3.2M63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)23K—$030K
Jun 24, 2026Option exercise(M)9K—$032K
Jun 24, 2026Option exercise(M)3K—$06K
Jun 24, 2026Option exercise(M)1K—$029K
Jun 24, 2026Option exercise(M)188—$06K
Jun 24, 2026Option exercise(M)822—$031K
Jun 24, 2026Option exercise(M)1K—$028K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML